HUPO brain proteome project: aims and needs in proteomics

被引:31
作者
Hamacher, M [1 ]
Meyer, HE [1 ]
机构
[1] Med Proteom Ctr, D-44801 Bochum, Germany
关键词
D O I
10.1586/14789450.2.1.1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 12 条
[1]   Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides [J].
Bibl, M ;
Esselmann, H ;
Otto, M ;
Lewczuk, P ;
Cepek, L ;
Rüther, E ;
Kornhuber, J ;
Wiltfang, J .
ELECTROPHORESIS, 2004, 25 (17) :2912-2918
[2]   Towards data management of the HUPO human brain Proteome Project pilot phase [J].
Blüggel, M ;
Bailey, S ;
Körting, G ;
Stephan, C ;
Reidegeld, KA ;
Thiele, H ;
Apweiler, R ;
Hamacher, M ;
Meyer, HE .
PROTEOMICS, 2004, 4 (08) :2361-2362
[3]  
HAMACHER M, 2004, 2 HUPO HBPP WORKSH P, V7, P1932
[4]   Building a foundation for the human proteome: The role of the human proteome organization [J].
Hanash, S .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (02) :197-199
[5]   HUPO initiatives relevant to clinical proteomics [J].
Hanash, S .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :298-301
[6]  
MARCUS K, 2004, INT REV NEUROLOGY
[7]   HBPP and the pursuit of standardisation [J].
Meyer, HE ;
Klose, J ;
Hamacher, M .
LANCET NEUROLOGY, 2003, 2 (11) :657-658
[8]   Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases [J].
Steinacker, P ;
Mollenhauer, B ;
Bibl, M ;
Cepek, L ;
Esselmann, H ;
Brechlin, P ;
Lewczuk, P ;
Poser, S ;
Kretzschmar, HA ;
Wiltfang, J ;
Trenkwalder, C ;
Otto, M .
NEUROSCIENCE LETTERS, 2004, 370 (01) :36-39
[9]   Between-gel reproducibility of the human cerebrospinal fluid proteome [J].
Terry, DE ;
Desiderio, DM .
PROTEOMICS, 2003, 3 (10) :1962-1979
[10]   What do we want from proteomics in the detection and avoidance of adverse drug reactions [J].
Wilkins, MR .
TOXICOLOGY LETTERS, 2002, 127 (1-3) :245-249